The AJMC® Medicare compendium is a comprehensive resource for clinical news and expert insights on issues that affect Medicare beneficiaries with a focus on polypharmacy, reimbursement challenges, and other topics related to seniors.
May 6th 2024
The Medicare trust fund is now expected to deplete in 2036, with the Inflation Reduction Act being credited for at least some of the extension.
February 14th 2024
Contributor: 3 Ways Health Plans Can Ensure Risk Adjustment Compliance
February 15th 2022By making diligent compliance efforts a priority in the years ahead, health plans can shore up existing processes to achieve financial success and ensure risk adjustment as regulatory bodies take aim at organizational missteps.
Read More
What We're Reading: COVID-19 Vaccine Expansion Halted; PBM Probe; High-Volume Antibiotic Prescribers
February 14th 2022The FDA delays its decision on Pfizer/BioNTech’s COVID-19 vaccine in young children; the Federal Trade Commission (FTC) will vote on whether to investigate pharmacy benefit managers (PBMs); nearly half of high-volume antibiotic prescribers are located in Southern states.
Read More
Association of Opioid Utilization Management With Prescribing and Overdose
Opioid utilization management in Medicare was associated with mixed effects on opioid prescribing, and prior authorization was associated with a decreased likelihood of subsequent overdose.
Read More
Value-Based Care Through Postacute Home Health Under CMS PACT Regulations
Among a patient population defined by CMS postacute care transfer regulations, home health vs no postacute care was associated with reduced 30-day readmissions and costs.
Read More
Behavioral Therapy Can Help Reduce Polypharmacy in Borderline Personality Disorder, Study Finds
February 3rd 2022Results of a retrospective study conducted in Spain found that dialectical-behavioral therapy skills training can help mitigate polypharmacy in those with borderline personality disorder.
Read More
Number of Accountable Care Organizations Joining MSSP in 2022 Grew Slightly, CMS Says
January 26th 2022In its annual Medicare Shared Savings Program (MSSP) report, CMS said the number of accountable care organizations joining increased, but a trade group said the results should have been better.
Read More
Polypharmacy Linked With Rehospitalization, Death Among Patients With HF
January 19th 2022An analysis conducted in Japan among patients with acute decompensated heart failure (HF) revealed excessive polypharmacy at hospital discharge is associated with an increased risk of mortality after 1 year.
Read More
CMS Says It Will Limit Biogen’s AD Drug to Patients in Clinical Trials
January 11th 2022In a National Coverage Determination decision memo released Tuesday, CMS said it will gather public comment for 30 days about its plan to limit coverage for Alzheimer disease (AD) biologics that target plaque buildup in the brain to patients enrolled in certain clinical trials.
Read More
Increased Patient-Physician Dialogue in EDs May Reduce Polypharmacy in Older Patients
January 8th 2022A Danish study observed emergency department (ED) health care providers and identified 5 factors that could play into patient involvement in medication discussions, particularly in older patients with polypharmacy.
Read More
Contributor: Should Insurance Regulation Be Used to Promote Nontraditional Goals?
December 17th 2021Three policies to revamp insurance consumer protections for health care delivery are explored, with highlighted areas for improvement being maternal health coverage and loosening of network adequacy requirements.
Read More
Antibodies produced by vaccinated people may be less successful at fighting against Omicron compared with other variants; Congressional leaders created a plan to lift the debt limit with only Democratic votes in the Senate, staving off Medicare cuts; cases of depression and anxiety among youths both doubled during the pandemic.
Read More